[Form 4] Murphy USA Inc. Insider Trading Activity
Rhea-AI Filing Summary
Deming Claiborne P, a director of Murphy USA Inc. (MUSA), received 80.128 restricted stock units (RSUs) on 09/30/2025 under the company’s 2023 Omnibus Incentive Plan in lieu of his quarterly cash retainer. The RSUs are fully vested when granted and the reporting person has elected to defer settlement of the RSUs and accrued dividend equivalent units until termination of Board service.
Following the reported grant, the filing shows the reporting person beneficially owns 868.612 shares (directly). The RSUs carry no conversion/exercise price and are reported at a price of $0. The Form 4 was signed on behalf of the reporting person by Gregory L. Smith, attorney-in-fact on 10/01/2025.
Positive
- Equity alignment: Director compensation delivered as RSUs aligns director interests with shareholders by increasing equity ownership over time.
- Deferral election: Settlement deferred until termination, suggesting long-term retention incentives and tax-efficient design for the director.
Negative
- No immediate cash purchase: The award was issued in lieu of cash, so it does not represent the director investing additional personal funds in the company.
Insights
TL;DR: Director received fully vested RSUs as cash-in-lieu of retainer and elected to defer settlement, a common director compensation approach.
The grant of 80.128 RSUs in lieu of a cash retainer indicates the company offers equity-based compensation to align director interests with shareholders. The RSUs are fully vested at grant and settlement is deferred until termination, which preserves tax-deferral and aligns long-term ownership incentives. Reporting 868.612 shares beneficially owned gives context to the director’s current direct stake. No exercise price or expiration applies, consistent with deferred stock unit structures for non-employee directors.
TL;DR: A routine, non-cash director compensation transaction with limited immediate market impact.
The transaction code and structure reflect an award under the 2023 Omnibus Incentive Plan converting cash retainer into 80.128 RSUs. Because RSUs were issued fully vested and settlement is deferred, there is no immediate market sale or purchase pressure and the reported price is $0, as typical for grant reporting. The inclusion of dividend equivalent units modestly increases long-term economic exposure but is not a material dilution event for investors given the size disclosed.